Form 4 for RGEN REPLIGEN CORP
Accepted 2026-06-26 16:05:11 ET · period of report 2026-06-25 · accession 0001193125-26-285449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-26 16:05 | 2026-06-25 | RGEN | Garland Jason K | CFO | S - Sale | $145.00 | -733 | 19.4K | -4% | -$106.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-25 | S | D | 733 | $145.00 | 19,359 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025. |